nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0777	0.104	CbGeAlD
Orphenadrine—GRIN1—midbrain—Gilles de la Tourette syndrome	0.0322	0.0431	CbGeAlD
Orphenadrine—GRIN2D—nervous system—Gilles de la Tourette syndrome	0.0297	0.0398	CbGeAlD
Orphenadrine—GRIN2D—central nervous system—Gilles de la Tourette syndrome	0.0286	0.0383	CbGeAlD
Orphenadrine—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.028	0.0374	CbGeAlD
Orphenadrine—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.0269	0.036	CbGeAlD
Orphenadrine—GRIN1—nervous system—Gilles de la Tourette syndrome	0.0265	0.0355	CbGeAlD
Orphenadrine—GRIN1—central nervous system—Gilles de la Tourette syndrome	0.0255	0.0341	CbGeAlD
Orphenadrine—SCN9A—midbrain—Gilles de la Tourette syndrome	0.0252	0.0338	CbGeAlD
Orphenadrine—GRIN2D—brain—Gilles de la Tourette syndrome	0.0227	0.0304	CbGeAlD
Orphenadrine—SCN1A—midbrain—Gilles de la Tourette syndrome	0.0217	0.0291	CbGeAlD
Orphenadrine—GRIN3A—brain—Gilles de la Tourette syndrome	0.0214	0.0286	CbGeAlD
Orphenadrine—GRIN1—brain—Gilles de la Tourette syndrome	0.0203	0.0271	CbGeAlD
Orphenadrine—SCN4A—nervous system—Gilles de la Tourette syndrome	0.0185	0.0248	CbGeAlD
Orphenadrine—SCN1A—nervous system—Gilles de la Tourette syndrome	0.0179	0.0239	CbGeAlD
Orphenadrine—SCN4A—central nervous system—Gilles de la Tourette syndrome	0.0178	0.0239	CbGeAlD
Orphenadrine—SCN1A—central nervous system—Gilles de la Tourette syndrome	0.0172	0.023	CbGeAlD
Orphenadrine—SCN9A—brain—Gilles de la Tourette syndrome	0.0159	0.0212	CbGeAlD
Orphenadrine—SCN10A—nervous system—Gilles de la Tourette syndrome	0.0158	0.0211	CbGeAlD
Orphenadrine—SCN10A—central nervous system—Gilles de la Tourette syndrome	0.0152	0.0204	CbGeAlD
Orphenadrine—SCN5A—nervous system—Gilles de la Tourette syndrome	0.0144	0.0192	CbGeAlD
Orphenadrine—SCN4A—brain—Gilles de la Tourette syndrome	0.0142	0.0189	CbGeAlD
Orphenadrine—SCN5A—central nervous system—Gilles de la Tourette syndrome	0.0138	0.0185	CbGeAlD
Orphenadrine—SCN1A—brain—Gilles de la Tourette syndrome	0.0136	0.0183	CbGeAlD
Orphenadrine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.0122	0.0164	CbGeAlD
Orphenadrine—SCN10A—brain—Gilles de la Tourette syndrome	0.0121	0.0162	CbGeAlD
Orphenadrine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.0118	0.0158	CbGeAlD
Orphenadrine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0117	0.0694	CbGpPWpGaD
Orphenadrine—SCN5A—brain—Gilles de la Tourette syndrome	0.011	0.0147	CbGeAlD
Orphenadrine—Captodiame—DRD3—Gilles de la Tourette syndrome	0.0109	0.13	CrCbGaD
Orphenadrine—GRIN2D—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0109	0.0647	CbGpPWpGaD
Orphenadrine—KCNH2—midbrain—Gilles de la Tourette syndrome	0.0107	0.0144	CbGeAlD
Orphenadrine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00983	0.0132	CbGeAlD
Orphenadrine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00947	0.0127	CbGeAlD
Orphenadrine—CHRM2—brain—Gilles de la Tourette syndrome	0.00934	0.0125	CbGeAlD
Orphenadrine—KCNH2—nervous system—Gilles de la Tourette syndrome	0.00883	0.0118	CbGeAlD
Orphenadrine—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.0085	0.0114	CbGeAlD
Orphenadrine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00837	0.0497	CbGpPWpGaD
Orphenadrine—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.00789	0.0935	CrCbGaD
Orphenadrine—GRIN1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0078	0.0463	CbGpPWpGaD
Orphenadrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00777	0.0461	CbGpPWpGaD
Orphenadrine—SLC6A2—brain—Gilles de la Tourette syndrome	0.00752	0.0101	CbGeAlD
Orphenadrine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.00725	0.0097	CbGeAlD
Orphenadrine—HRH1—nervous system—Gilles de la Tourette syndrome	0.00708	0.00947	CbGeAlD
Orphenadrine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.00698	0.00934	CbGeAlD
Orphenadrine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.00681	0.00912	CbGeAlD
Orphenadrine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.0068	0.0091	CbGeAlD
Orphenadrine—KCNH2—brain—Gilles de la Tourette syndrome	0.00675	0.00903	CbGeAlD
Orphenadrine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.00655	0.00876	CbGeAlD
Orphenadrine—Benzatropine—SLC6A3—Gilles de la Tourette syndrome	0.00605	0.0717	CrCbGaD
Orphenadrine—CYP2B6—brain—Gilles de la Tourette syndrome	0.00554	0.00741	CbGeAlD
Orphenadrine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00547	0.00732	CbGeAlD
Orphenadrine—HRH1—brain—Gilles de la Tourette syndrome	0.00541	0.00724	CbGeAlD
Orphenadrine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00539	0.032	CbGpPWpGaD
Orphenadrine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00527	0.00705	CbGeAlD
Orphenadrine—CYP2E1—brain—Gilles de la Tourette syndrome	0.0052	0.00696	CbGeAlD
Orphenadrine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.00512	0.0304	CbGpPWpGaD
Orphenadrine—Chlorphenamine—SLC6A3—Gilles de la Tourette syndrome	0.00458	0.0544	CrCbGaD
Orphenadrine—Modafinil—SLC6A3—Gilles de la Tourette syndrome	0.00448	0.0531	CrCbGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00445	0.0264	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00437	0.026	CbGpPWpGaD
Orphenadrine—Benzphetamine—SLC6A3—Gilles de la Tourette syndrome	0.00388	0.046	CrCbGaD
Orphenadrine—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.00385	0.0457	CrCbGaD
Orphenadrine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00379	0.0225	CbGpPWpGaD
Orphenadrine—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.00377	0.0447	CrCbGaD
Orphenadrine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00373	0.0222	CbGpPWpGaD
Orphenadrine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00368	0.0219	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00362	0.0215	CbGpPWpGaD
Orphenadrine—Fluoxetine—HTR2A—Gilles de la Tourette syndrome	0.00345	0.0408	CrCbGaD
Orphenadrine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00343	0.0204	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00337	0.02	CbGpPWpGaD
Orphenadrine—Promazine—DRD4—Gilles de la Tourette syndrome	0.00334	0.0397	CrCbGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00319	0.0189	CbGpPWpGaD
Orphenadrine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.00317	0.0376	CrCbGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00314	0.0186	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00309	0.0184	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00304	0.0181	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00288	0.0171	CbGpPWpGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00284	0.0168	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00256	0.0152	CbGpPWpGaD
Orphenadrine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.00251	0.0298	CrCbGaD
Orphenadrine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0024	0.0143	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00236	0.014	CbGpPWpGaD
Orphenadrine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.00236	0.0279	CrCbGaD
Orphenadrine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.00235	0.0279	CrCbGaD
Orphenadrine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.00227	0.0269	CrCbGaD
Orphenadrine—Doxepin—DRD2—Gilles de la Tourette syndrome	0.00225	0.0266	CrCbGaD
Orphenadrine—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.00221	0.0262	CrCbGaD
Orphenadrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00211	0.0125	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00202	0.012	CbGpPWpGaD
Orphenadrine—Promazine—DRD2—Gilles de la Tourette syndrome	0.002	0.0237	CrCbGaD
Orphenadrine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00199	0.0118	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00196	0.0116	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00183	0.0109	CbGpPWpGaD
Orphenadrine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.00182	0.0216	CrCbGaD
Orphenadrine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.00175	0.0208	CrCbGaD
Orphenadrine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.00175	0.0207	CrCbGaD
Orphenadrine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.00174	0.0206	CrCbGaD
Orphenadrine—Doxepin—HTR2A—Gilles de la Tourette syndrome	0.00174	0.0206	CrCbGaD
Orphenadrine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00166	0.00984	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00161	0.00955	CbGpPWpGaD
Orphenadrine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.00154	0.0183	CrCbGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00154	0.00914	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00152	0.00903	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0014	0.00834	CbGpPWpGaD
Orphenadrine—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.00135	0.016	CrCbGaD
Orphenadrine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0159	CrCbGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00132	0.00785	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00128	0.00761	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00117	0.00695	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MET—Gilles de la Tourette syndrome	0.00105	0.00626	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00623	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MET—Gilles de la Tourette syndrome	0.000969	0.00575	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000958	0.00569	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MET—Gilles de la Tourette syndrome	0.000934	0.00555	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MET—Gilles de la Tourette syndrome	0.000934	0.00555	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000776	0.00461	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MET—Gilles de la Tourette syndrome	0.000764	0.00454	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000753	0.00447	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000752	0.00447	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000732	0.00435	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00072	0.00428	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00071	0.00422	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000702	0.00417	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000699	0.00415	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000691	0.00411	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000682	0.00405	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000667	0.00396	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000667	0.00396	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000662	0.00393	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MET—Gilles de la Tourette syndrome	0.000657	0.0039	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000651	0.00387	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000627	0.00372	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000617	0.00366	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000609	0.00361	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0006	0.00356	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000599	0.00356	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000567	0.00337	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000558	0.00331	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000545	0.00324	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000536	0.00318	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000487	0.00289	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000477	0.00283	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00047	0.00279	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000469	0.00278	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000463	0.00275	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000463	0.00275	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000456	0.00271	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000456	0.00271	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000432	0.00256	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000425	0.00252	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000397	0.00236	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000391	0.00232	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000391	0.00232	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000383	0.00228	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000302	0.0018	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000298	0.00177	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00027	0.0016	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000265	0.00158	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000262	0.00156	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000258	0.00153	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000245	0.00145	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000244	0.00145	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000241	0.00143	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00024	0.00143	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000238	0.00141	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000234	0.00139	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000222	0.00132	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000218	0.00129	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000178	0.00106	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000171	0.00101	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000168	0.000998	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000155	0.000921	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000153	0.000907	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000145	0.000859	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000142	0.000846	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00014	0.000834	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000138	0.000821	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000131	0.000777	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000129	0.000765	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.17e-05	0.000544	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.02e-05	0.000536	CbGpPWpGaD
